Fibrosis and Scar-Related Electrical Remodeling
Fibrosis and scar tissue alter cardiac electrical activity, leading to arrhythmias through structural and functional remodeling of heart tissue.
Fibrosis and scar-related electrical remodeling refers to the structural and functional alterations in cardiac tissue that occur due to the development of fibrotic deposits and scar formation following injury, inflammation, or chronic pathological stimuli. These changes disrupt the normal electrical conduction pathways within the myocardium, leading to heterogeneous conduction, altered refractory periods, and increased arrhythmogenic potential.
Pathophysiology of Fibrosis and Scar Formation
Mechanisms of Fibrosis Development
Fibrosis in the heart results from an imbalance between extracellular matrix (ECM) synthesis and degradation. Cardiac injury triggers activation of fibroblasts and their differentiation into myofibroblasts, which secrete excessive amounts of collagen types I and III, glycoproteins, and proteoglycans. This fibrotic ECM accumulation replaces normal myocardial tissue, increasing stiffness and impairing electrical continuity.
Scar Formation after Myocardial Injury
Scar formation is the endpoint of the wound healing response after myocardial infarction or other insults. Necrotic myocytes are replaced by dense collagenous tissue devoid of contractile function. Unlike fibrosis, which may be diffuse or patchy, scars are well-demarcated regions of dense fibrotic tissue that electrically isolate affected areas from surrounding myocardium, creating anatomical barriers to conduction.
Impact on Cardiac Electrical Properties
Disruption of Electrical Conduction
Fibrotic and scarred tissue lacks the ion channel expression and gap junction connectivity typical of cardiomyocytes, resulting in areas of conduction block or slowed conduction velocity. This creates heterogeneous conduction pathways and promotes anisotropic conduction, favoring re-entrant circuits and conduction delays.
Alterations in Electrotonic Coupling
The replacement of cardiomyocytes with fibroblasts or scar tissue reduces the density and function of gap junction proteins such as connexin 43. Fibroblasts do not conduct action potentials but may electrically couple heterogeneously to myocytes, further disrupting impulse propagation and contributing to spatial dispersion of depolarization.
Changes in Action Potential Duration and Refractoriness
Fibrosis can indirectly modulate cardiomyocyte electrophysiology by altering local mechanical and paracrine signaling environments. This leads to regional differences in ion channel expression and function, causing dispersion in action potential duration and refractory periods. These electrical heterogeneities increase vulnerability to arrhythmogenesis.
Role in Arrhythmogenesis
Substrate for Reentrant Arrhythmias
Fibrotic and scar tissue create anatomical and functional obstacles that facilitate re-entrant arrhythmias. Areas of slow conduction around fibrotic patches or scars allow re-excitation of myocardium when the tissue has recovered excitability, sustaining arrhythmic circuits such as atrial fibrillation or ventricular tachycardia.
Triggering and Maintenance of Focal Arrhythmias
Besides reentry, fibrosis can promote abnormal automaticity and triggered activity by altering the electrophysiological milieu. The disrupted electrotonic interactions and altered ion channel function may lead to ectopic foci originating near fibrotic regions, perpetuating arrhythmias.
Clinical Implications
Diagnostic Considerations
Fibrosis and scar-related remodeling can be identified by imaging modalities such as late gadolinium enhancement cardiac magnetic resonance (LGE-CMR), which visualizes fibrotic tissue, and electroanatomical mapping, which detects areas of low voltage and conduction abnormalities.
Therapeutic Approaches
Interventions targeting fibrosis and scar-related electrical remodeling include pharmacological agents that modulate fibrotic pathways, catheter ablation to eliminate arrhythmogenic substrates, and device therapy such as implantable cardioverter-defibrillators (ICDs) to prevent sudden cardiac death in patients with significant scar-related arrhythmias.
Molecular and Cellular Basis
Fibroblast-Myocyte Interactions
Cardiac fibroblasts contribute to remodeling not only by ECM deposition but also by paracrine signaling that influences myocyte electrophysiology. Fibroblast secretion of cytokines and growth factors modulates ion channel expression and gap junction remodeling in adjacent myocytes.
Ion Channel Remodeling
Fibrosis-associated remodeling includes downregulation of sodium and potassium channels in cardiomyocytes near fibrotic tissue, reducing conduction velocity and altering repolarization. This ion channel remodeling exacerbates electrical heterogeneity and arrhythmic risk.
Summary of Electrical Remodeling Features
| Feature | Description |
|---|---|
| Conduction slowing | Due to loss of myocytes and reduced gap junction expression |
| Conduction block | Areas of dense fibrosis and scar tissue impede impulse flow |
| Increased anisotropy | Direction-dependent conduction velocity changes |
| Dispersion of refractoriness | Regional heterogeneity in action potential duration |
| Enhanced arrhythmogenic substrate | Facilitation of reentry and focal arrhythmias |
Fibrosis and scar-related electrical remodeling constitute a critical component of the pathophysiology underlying many cardiac arrhythmias by structurally and functionally altering myocardial conduction properties, creating a substrate that predisposes to life-threatening rhythm disturbances.